Clinical Trial Update: The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial of CD-801 for advanced intrahepatic cholangiocarcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CD-801

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Intrahepatic Cholangiocarcinoma | EARLY_Phase 1 | Status: WITHDRAWN